Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AP Pharma And Ziopharm: The Differences Between Bad News
Seeking Alpha
Monday, April 1, 2013 - 10:30am
tags:
Ziopharm, AP Pharma, APF530, chemotherapy-induced nausea and vomiting
3 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, March 30, 2013 - 11:04am
tags:
Corcept Therapeutics, Vivus, Cempra
Pfizer May Have To Rethink Xalkori Cost Structure
Seeking Alpha
Saturday, March 30, 2013 - 11:02am
tags:
Pfizer, Xalkori, lung cancer
FDA OKs first-of-a-kind diabetes drug from J&J
Yahoo/AP
Saturday, March 30, 2013 - 11:01am
tags:
JNJ, diabetes, Invokana, type 2 diabetes
This Pharma's Dividend Is Safe for Now
Motley Fool
Saturday, March 30, 2013 - 10:57am
tags:
Eli Lilly
Celgene's Star Drug Revlimid And Its Competitors
Seeking Alpha
Saturday, March 30, 2013 - 10:57am
tags:
Celgene, Revlimid, Multiple Myeloma, JNJ, Velcade, AbbVie, Bristol-Myers Squibb, elotuzumab
Is This Biotech A Value Stock Or Value Trap?
Seeking Alpha
Saturday, March 30, 2013 - 10:41am
tags:
Omeros
Questions That Must Be Answered For The Success Of Probuphine
Seeking Alpha
Saturday, March 30, 2013 - 10:40am
tags:
Probuphine, opiod addiction
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, March 30, 2013 - 10:38am
tags:
Repros Therapeutics, Endocyte, Sarepta Therapeutics
Biogen prices new MS drug at discount to key competitors
Reuters
Saturday, March 30, 2013 - 10:37am
tags:
Biogen, Tecfidera, multiple sclerosis, MS
The Oncology Stock to Buy Today
Motley Fool
Saturday, March 30, 2013 - 10:35am
tags:
ONYX Pharmaceuticals
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, March 30, 2013 - 10:34am
tags:
Ziopharm, Idenix, Vanguard Health Systems
Intellect Neurosciences Issues Letter to Shareholders
Yahoo/GlobeNewsWire
Saturday, March 30, 2013 - 10:32am
tags:
Intellect Neurosciences, Conjumab
Discovery Labs Announces Newly-Released Surfaxin (lucinactant) Publications
Yahoo/PR Newswire
Saturday, March 30, 2013 - 10:30am
tags:
Discovery Labs, Surfaxin
Declines From Seattle Genetics Inc. (SGEN) Drive Down Health Care Sector
TheStreet.com
Friday, March 29, 2013 - 11:23am
tags:
Seattle Genetics
Array BioPharma: An Exciting Year Ahead
Seeking Alpha
Friday, March 29, 2013 - 11:23am
tags:
Array Biopharma
Biogen Reveals Pricing For New MS Drug Tecfidera
Forbes
Friday, March 29, 2013 - 11:17am
tags:
Biogen, MS, multiple sclerosis, Tecfidera
3 Attractive Healthcare Dividend Stocks
Motley Fool
Friday, March 29, 2013 - 11:17am
tags:
AbbVie, dividend, AstraZeneca
RXi Pharmaceuticals Reports Full Year 2012 Financial Results
Yahoo
Friday, March 29, 2013 - 11:13am
tags:
RXi Pharmaceuticals, earnings
BD Forms Pharmaceutical Wing with New Prefilled Generic Injectables
in-Pharma Technologist
Friday, March 29, 2013 - 11:05am
tags:
injectables, Becton Dickinson

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.